XM does not provide services to residents of the United States of America.

3M CFO Patolawala to leave company, to serve as ADM's new finance chief



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 4-ADM names 3M's Patolawala as its CFO amid US government investigation</title></head><body>

Recasts paragraph 1, adds details and background between paragraphs 4-9

July 10 (Reuters) -Archer-Daniels-Midland ADM.N named manufacturing giant 3M's MMM.N Monish Patolawala as its CFO on Wednesday, as the grain trader tries to steer its way through multiple U.S. governmentinvestigations related to accounting irregularities.

Patolawala's appointment at ADM will be effective Aug. 1, the company said. He will succeed interim CFO Ismael Roig, who has been serving in his role since January 2024.

In March, ADM had corrected six years of financial data after an internal investigation found some sales between business units within the company were not recorded properly.

ADM had put its then CFO Vikram Luthar on administrative leave in January before announcing his departure from the company in April.

"I think the move signals the board wanted to hire an outside CFO candidate as a way to start fresh following the accounting issues," Morningstar analyst Seth Goldstein said.

ADM said Patolawala would have an initial annual base salary of $1.425 million.

3M shares were down while ADM was up marginally in morning trade.

Some Wall Street analysts said Patolawala's departure from 3M was expected as he was likely passed over for the role of CEO for industry veteran Bill Brown.

"We thought highly of Monish, and consider his four-year tenure at 3M to have been a success with clear and consistent messaging and the smoothly orchestrated Health Care spin," RBC Capital Markets analyst Deane Dray wrote in a note.

3M rolled out a major restructuring last year that includes cutting thousands of jobs and the spinoff of its healthcare business into a listed company, to mitigate the slowdown in demand.





Reporting by Nathan Gomes, Abhinav Parmar, Sourasis Bose, Seher Dareen and Shivansh Tiwary in Bengaluru; Editing by Krishna Chandra Eluri

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.